A recent increase in demand for personal protective equipment (PPE) has caused delays for some products ordered by U.S. hospitals for Ebola preparedness. Across the United States, availability for these products varies by product type and model, manufacturer, distributor and geographic region. According to the Centers for Disease Control and Prevention (CDC), there are a number of options available for hospitals needing to increase their PPE supplies despite manufacturer shortages and delays. The role a hospital plays in preparing to identify, isolate, evaluate, and, in some cases, treat patients with possible Ebola virus disease is the most important indicator of how much PPE is needed. To provide state health departments and hospitals with more information on how to increase PPE supply, CDC has issued new guidance, "Considerations for U.S Healthcare Facilities to Ensure Adequate Supplies of Personal Protective Equipment (PPE) for Ebola Preparedness." This resource summarizes the current U.S. PPE supply situation and provides recommendations for ways healthcare facilities can increase PPE as part of their Ebola preparedness planning efforts.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.